Results of inpatient pediatric resuscitation.

We retrospectively reviewed the results of 42 cardiopulmonary arrests occurring over 1 yr in the general ward of a pediatric hospital. These data were compared to those of a similar study done 10 yr previously in the same institution. Patients were divided into those having pure respiratory arrest and those who also had cardiac arrest. In the most recent series, overall 6-month survival was 17%; however, only 9% of the cardiac arrest patients survived. Ten years previously, the survival rate from cardiac arrest was 11%. In both series, pure respiratory arrest had a significantly better outcome than cardiopulmonary arrest, and predictors of nonsurvival were a duration of arrest greater than 15 min and the administration of more than one iv bolus of epinephrine. During the more recent series, sepsis and upper airway problems produced fewer arrests. There was one neurologically damaged survivor in each study period. Our study confirms that the outcome of pediatric cardiac arrest is poor when arrest occurs in the hospital.
AuthorsJ Gillis, D Dickson, M Rieder, D Steward, J Edmonds
JournalCritical care medicine (Crit Care Med) Vol. 14 Issue 5 Pg. 469-71 (May 1986) ISSN: 0090-3493 [Print] UNITED STATES
PMID3698612 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Epinephrine
  • Adolescent
  • Child
  • Child, Preschool
  • Epinephrine (administration & dosage)
  • Female
  • Follow-Up Studies
  • Heart Arrest (complications, mortality, therapy)
  • Hospital Bed Capacity, 500 and over
  • Hospitals, Pediatric
  • Humans
  • Infant
  • Infant, Newborn
  • Injections
  • Inpatients
  • Male
  • Ontario
  • Outcome and Process Assessment (Health Care)
  • Patients
  • Probability
  • Resuscitation
  • Retrospective Studies
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: